Suchergebnisse - "Castagna, Luca"

PubPharm (262)

71

Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2019

von Mariotti, J. | Devillier, R. | Bramanti, S. | +16

72

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide

enthalten in: Bone marrow transplantation | 2019

von Mariotti, J. | Granata, A. | Bramanti, S. | +12

73

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation : A Randomized Clinical Trial

enthalten in: JAMA | 2019

von Bastidas, A. | de la Serna, J. | El Idrissi, M. | +128

ErratumIn: JAMA. 2019 Aug 27;322(8):785. - PMID 31454023

74

Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide : Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2019

von Bramanti, S. | Calafiore, V. | Longhi, E. | +7

75

Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies : a single-center experience of 209 patients

enthalten in: Bone marrow transplantation | 2019

von Pagliardini, T. | Harbi, S. | Fürst, S. | +13

76

Correction : The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

enthalten in: Bone marrow transplantation | 2019

von Ciurea, S. | Cao, K. | Fernandez-Vina, M. | +21

ErratumFor: Bone Marrow Transplant. 2018 May;53(5):521-534. - PMID 29335625

77

Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies : a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells

enthalten in: British journal of haematology | 2019

von Cauchois, R. | Castagna, L. | Pagliardini, T. | +13

78

Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide

enthalten in: European journal of haematology | 2019

von Mariotti, J. | De Philippis, C. | Bramanti, S. | +7

79

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL

enthalten in: Blood advances | 2019

von Dreger, P. | Sureda, A. | Ahn, K. | +23

80

Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Locatelli, S. | Careddu, G. | Serio, S. | +9